Modeling and Simulation as a Tool to Bridge Efficacy and Safety Data in Special Populations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modeling and Simulation as a Tool to Bridge Efficacy and Safety Data in Special Populations

Published:2013-02 Issue:2 Volume:2 Page:28
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Harnisch L¹,Shepard T²³,Pons G³⁴,Della Pasqua O⁵

Affiliation:

1. Pfizer, Pharmacometrics, Global Clinical Pharmacology; Sandwich UK

2. Statistics Unit, Medicines and Healthcare products Regulatory Agency; London UK

3. European Medicines Agency; London UK

4. University Paris-Descartes, UMR Inserm; Paris France

5. Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline; Uxbridge UK

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2013.6/fullpdf

Reference10 articles.

1. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2;Hoaglin;Value Health,2011

2. Statistical approaches for conducting network meta-analysis in drug development;Jones;Pharm. Stat.,2011

3. Proposals for model-based paediatric medicinal development within the current European Union regulatory framework;Manolis;Br. J. Clin. Pharmacol.,2009

4. A model-based approach to dose selection in early pediatric development;Cella;Clin. Pharmacol. Ther.,2010

5. Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin;Yuen;J. Pharmacokinet. Pharmacodyn.,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review;Pediatric Drugs;2024-04-18

2. A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development;Journal of Pharmacokinetics and Pharmacodynamics;2023-03-04

3. Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response;British Journal of Clinical Pharmacology;2022-02-17

4. Scientific and regulatory evaluation of empirical pharmacometric models: An application of the risk informed credibility assessment framework;CPT: Pharmacometrics & Systems Pharmacology;2021-10-08

5. Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification;Pharmacology Research & Perspectives;2021-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3